共 222 条
[1]
Jemal A(2011)Global cancer statistics CA Cancer J Clin 61 69-90
[2]
Bray F(1990)Gastric cancer: a 25-year review Br J Surg 77 353-1321
[3]
Center MM(2011)Past and present achievements, and future direction of the Gastrointestinal Oncology Study Group (GIOSG), a Division of Japan Clinical Oncology Group (JCOG) Jpn J Clin Oncol 41 1315-628
[4]
Ferlay J(2014)Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors Int J Cancer 134 622-262
[5]
Ward E(1999)Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma Am J Surg 178 256-697
[6]
Forman D(2010)Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial Lancet (London, England) 376 687-267
[7]
Allum WH(1997)Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer J Clin Oncol 15 261-3209
[8]
Fielding JW(2010)Chemotherapy for advanced gastric cancer Cochrane Database Syst Rev 3 CD004064-1581
[9]
Boku N(2007)Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group J Clin Oncol 25 3205-698
[10]
Thomassen I(2011)Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial Ann Surg Oncol 18 1575-633